| dbo:abstract
|
- SOPHiA GENETICS is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B. (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:locationCity
| |
| dbo:numberOfEmployees
|
- 500 (xsd:nonNegativeInteger)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 20274 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founded
| |
| dbp:founders
|
- (en)
- Dr. Jurgi Camblong (en)
- Dr. Pierre Hutter (en)
- Prof. Lars Steinmetz (en)
|
| dbp:hqLocationCity
| |
| dbp:industry
| |
| dbp:keyPeople
|
- (en)
- Dr. Jurgi Camblong, CEO (en)
- Philippe Menu, CMO (en)
- Ross Muken, CFO (en)
|
| dbp:logo
|
- Sophia Genetics logo.png (en)
|
| dbp:name
| |
| dbp:numEmployees
| |
| dbp:services
| |
| dbp:tradedAs
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- SOPHiA GENETICS is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
